Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Neuroscience ; 280: 275-81, 2014 Nov 07.
Artículo en Inglés | MEDLINE | ID: mdl-25194787

RESUMEN

Lipoprotein lipase (LPL) is expressed at high levels in hippocampal neurons, although its function is unclear. We previously reported that LPL-deficient mice have learning and memory impairment and fewer synaptic vesicles in hippocampal neurons, but properties of synaptic activity in LPL-deficient neurons remain unexplored. In this study, we found reduced frequency of miniature excitatory postsynaptic currents (mEPSCs) and readily releasable pool (RRP) size in LPL-deficient neurons, which led to presynaptic dysfunction and plasticity impairment without altering postsynaptic activity. We demonstrated that synaptic vesicle recycling, which is known to play an important role in maintaining the RRP size in active synapses, is impaired in LPL-deficient neurons. Moreover, lipid assay revealed deficient docosahexaenoic acid (DHA) and arachidonic acid (AA) in the hippocampus of LPL-deficient mice; exogenous DHA or AA supplement partially restored synaptic vesicle recycling capability. These results suggest that impaired synaptic vesicle recycling results from deficient DHA and AA and contributes to the presynaptic dysfunction and plasticity impairment in LPL-deficient neurons.


Asunto(s)
Hipocampo/fisiopatología , Lipoproteína Lipasa/deficiencia , Terminales Presinápticos/enzimología , Vesículas Sinápticas/enzimología , Animales , Ácido Araquidónico/administración & dosificación , Ácido Araquidónico/metabolismo , Ácidos Docosahexaenoicos/administración & dosificación , Ácidos Docosahexaenoicos/metabolismo , Potenciales Postsinápticos Excitadores/efectos de los fármacos , Potenciales Postsinápticos Excitadores/fisiología , Cromatografía de Gases y Espectrometría de Masas , Hipocampo/efectos de los fármacos , Hiperlipoproteinemia Tipo I/tratamiento farmacológico , Hiperlipoproteinemia Tipo I/fisiopatología , Lipoproteína Lipasa/genética , Masculino , Ratones Endogámicos C57BL , Potenciales Postsinápticos Miniatura/efectos de los fármacos , Potenciales Postsinápticos Miniatura/fisiología , Técnicas de Placa-Clamp , Terminales Presinápticos/efectos de los fármacos , Células Piramidales/efectos de los fármacos , Células Piramidales/fisiopatología , Vesículas Sinápticas/efectos de los fármacos , Técnicas de Cultivo de Tejidos
2.
Biomed Pharmacother ; 65(2): 132-6, 2011 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21227627

RESUMEN

SNX-2112 is a novel Hsp90 inhibitor. The aim of this study was to investigate the pharmacokinetics, tissue distribution, plasma protein binding and excretion profiles of SNX-2112 in Sprague-Dawley rats after a single intravenous injection. The pharmacokinetic properties of SNX-2112 were examined after a single i.v. injection of 2.5, 5, and 10mg/kg to rats, respectively. The tissue distribution and urinary, fecal, and biliary excretion patterns of SNX-2112 were investigated following a single i.v. injection of 10mg/kg. The results suggested that the pharmacokinetic properties of SNX-2112 fitted well into a two-compartment open model with t(1/2ß) values of 9.96±4.32, 10.43±4.06, 10.41±4.38h and area under the curve values of 7.62±1.03, 8.10±0.77, 15.80±1.00(µg/mL) h according to the single doses of 2.5, 5, and 10mg/kg, respectively. Approximately 0.13±0.09% and 3.62±0.77% of SNX-2112 were excreted via the urine and feces within 72h, respectively; 2.59±0.67% was excreted into the bile up to 24h after a single i.v. injection of 10mg/kg. The major elimination route was therefore through excretion in the feces. The binding rate of SNX-2112 with plasma protein was found to be concentration-dependent. In conclusion, this study first provided the full pharmacokinetic characteristics and tissue distribution of SNX-2112, which would be helpful for its clinical regiment design.


Asunto(s)
Proteínas HSP90 de Choque Térmico/antagonistas & inhibidores , Compuestos Heterocíclicos de 4 o más Anillos/farmacocinética , Modelos Biológicos , Animales , Área Bajo la Curva , Proteínas Sanguíneas/metabolismo , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos , Femenino , Semivida , Compuestos Heterocíclicos de 4 o más Anillos/administración & dosificación , Inyecciones Intravenosas , Masculino , Unión Proteica , Ratas , Ratas Sprague-Dawley , Factores de Tiempo , Distribución Tisular
3.
Brain Res ; 900(2): 227-33, 2001 May 11.
Artículo en Inglés | MEDLINE | ID: mdl-11334802

RESUMEN

Nitric oxide is involved in the mechanism of hyperbaric oxygen (HBO(2)) brain toxicity as nitric oxide synthase (NOS) inhibitors delay latent time before the onset of seizures. The purpose of this study was to investigate if seizures affect sensitivity to convulsions during subsequent exposure to HBO(2) and to determine if NOS activity and expression is changed after HBO(2) seizures. Rats were exposed to 5 atm (gauge pressure) 100% O(2) until seizures recorded by electroencephalograph (EEG) and reexposed 1, 2, or 6 days later. Latency to seizures was significantly shorter (P<0.05) in animals reexposed 1 or 2 days after the first exposure. Activity of calcium-dependent NOS activity in cortex was significantly higher 1 and 2 days after seizures compared with controls (P<0.05), while calcium-independent NOS activity was not changed during the 6-day post-seizure interval. The expression of neuronal NOS (nNOS) protein determined by Western blot was higher 1 and 2 days after seizures (P<0.05), while the expression of endothelial (eNOS) and inducible (iNOS) remained unchanged. nNOS upregulation 1 and 2 days after seizures and protection against HBO(2) seizures by nNOS-specific inhibitor 7-nitroindazole (7-NI) suggest possible involvement of NO in the mechanism of increased sensitivity to HBO(2) in reexposures.


Asunto(s)
Oxigenoterapia Hiperbárica , Óxido Nítrico Sintasa/metabolismo , Convulsiones/etiología , Animales , Calcio/fisiología , Corteza Cerebral/enzimología , Electroencefalografía , Activación Enzimática/fisiología , Inhibidores Enzimáticos/farmacología , Indazoles/farmacología , Masculino , Óxido Nítrico Sintasa/antagonistas & inhibidores , Óxido Nítrico Sintasa de Tipo I , Ratas , Ratas Sprague-Dawley , Tiempo de Reacción/fisiología , Valores de Referencia , Convulsiones/diagnóstico , Convulsiones/enzimología , Convulsiones/prevención & control , Factores de Tiempo
4.
J Agric Food Chem ; 49(1): 216-20, 2001 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11170580

RESUMEN

Grass pea seedlings were grown in an irrigated field. Roots of 15-day-old seedlings were treated with PEG, and leaves were studied. With the duration of PEG treatment, changes in the lipid peroxidation and activities of superoxide dismutase, catalase, peroxidase, and glutathione reductase as well as contents of hydrogen peroxide and beta-N-oxalyl-L-alpha,beta-diaminopropionic acid (ODAP) were assayed. The results indicate that with the duration of PEG treatment, activities of superoxide dismutase, peroxidase, and catalase decreased, whereas contents of hydrogen peroxide and ODAP, extent of lipid peroxidation, and activity of glutathione reductase increased. Both diethyldithiocarbamate and aminotriazole strongly inhibit activities of superoxide dismutase and catalase, respectively. At same time, the extent of lipid peroxidation was obviously increased. However, mannitol decreased the extent of lipid peroxidation. Diethyldithiocarbamate, aminotriazole, and mannitol do not affect the accumulation of ODAP. The observations suggest that there is no direct relationship between the accumulation of ODAP and the metabolism of free radicals. In addition, the relationship between water stress and ODAP accumulation in grass pea is discussed.


Asunto(s)
Aminoácidos Diaminos/metabolismo , Fabaceae/metabolismo , Plantas Medicinales , Agua , Catalasa/metabolismo , Fabaceae/crecimiento & desarrollo , Radicales Libres , Glutatión Reductasa/metabolismo , Peróxido de Hidrógeno/metabolismo , Peroxidación de Lípido , Peroxidasa/metabolismo , Polietilenglicoles/farmacología , Superóxido Dismutasa/metabolismo
5.
Genomics ; 63(3): 400-8, 2000 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-10704287

RESUMEN

We have identified and characterized a novel human ADP-ribosylation factor GTPase-activating protein (ARFGAP1) gene that is related to other members of the ARF GAP family. The full-length cDNA for human ARFGAP1 was cloned following the identification of an EST obtained by large-scale cDNA library sequencing through a Blast search of public databases. Structurally, ARFGAP1 encodes a polypeptide of 516 amino acids, which contained a typical GATA-1-type zinc finger motif (CXXCX(16)CXXC) with the four cysteine residues that are highly conserved among other members of the ARF GAP family. The conserved ARF GAP domain may emphasize the biological importance of this gene. The ARFGAP1 gene, which contained 16 exons ranging from 0.5 to 9.3 kb, was mapped to human chromosome 22q13.2-q13.3 using radiation hybridization and in silico analyses. ARFGAP1 is strongly expressed in endocrine glands and testis. Interestingly, the expression of ARFGAP1 in testis is about sixfold higher than that in ovary, indicating a possible role of ARFGAP1 in the physiological function of sperm. Expression of ARFGAP1 in four human fetal tissues and seven cancer cell lines was also detected.


Asunto(s)
Factores de Ribosilacion-ADP/genética , Cromosomas Humanos Par 22/genética , Proteínas Activadoras de GTPasa/genética , Genes , Familia de Multigenes , Dedos de Zinc/genética , Factores de Ribosilacion-ADP/biosíntesis , Secuencia de Aminoácidos , Secuencia de Bases , Mapeo Cromosómico , Clonación Molecular , ADN Complementario/genética , Glándulas Endocrinas/metabolismo , Exones/genética , Etiquetas de Secuencia Expresada , Proteínas Fetales/biosíntesis , Proteínas Fetales/genética , Proteínas Activadoras de GTPasa/biosíntesis , Expresión Génica , Biblioteca de Genes , Humanos , Pulmón/metabolismo , Masculino , Datos de Secuencia Molecular , Proteínas de Neoplasias/biosíntesis , Proteínas de Neoplasias/genética , Proteínas del Tejido Nervioso/biosíntesis , Proteínas del Tejido Nervioso/genética , Especificidad de Órganos , Testículo/metabolismo , Células Tumorales Cultivadas
7.
Zhongguo Yao Li Xue Bao ; 14 Suppl: S47-9, 1993 Nov.
Artículo en Chino | MEDLINE | ID: mdl-8010075

RESUMEN

The polysaccharides of Saussurea involucrata Kar et Kir was first isolated and identified by us. The polysaccharides scavenged superoxide anions by nitroblue tetraazolium colorimetric method with a median scavenging concentration of 22 micrograms.ml-1 and 95% confidence limit was 19.9-24.1 micrograms.ml-1. The polysaccharides inhibited the formation of thiobarbituric acid reaction substance in mouse liver homogenate and its IC50 was 2.3 mg/g fresh liver and 95% confidence limit was 2.05-2.55 mg/g fresh liver. By ip 25 mg.kg-1.d-1 x d in mice, the polysaccharides decreased oxygen consumption by 34.4% and ip same dosage x 6 d, the polysaccharide prolonged swimming time by 1.69-fold.


Asunto(s)
Medicamentos Herbarios Chinos/química , Depuradores de Radicales Libres , Esfuerzo Físico/efectos de los fármacos , Polisacáridos/farmacología , Animales , Medicamentos Herbarios Chinos/farmacología , Fatiga/prevención & control , Masculino , Malondialdehído/metabolismo , Ratones , Consumo de Oxígeno/efectos de los fármacos , Polisacáridos/aislamiento & purificación
8.
Zhongguo Zhong Yao Za Zhi ; 16(9): 520-2, 573, 1991 Sep.
Artículo en Chino | MEDLINE | ID: mdl-1804194

RESUMEN

This paper deals with a botanical survey and identification of the Chinese drug Shiwei (Folium Pyrrosiae) on the basis of three most widely used species included in the 1985 edition of Chinese Pharmacopoeia, six species used in some districts of China, and two adulterant species. Three active constituents in seven species of Folium Pyrrosiae (mangiferin, isomangiferin and chlorogenic acid) have been determined.


Asunto(s)
Medicamentos Herbarios Chinos/normas , Plantas Medicinales/anatomía & histología , Antivirales/análisis , Ácido Clorogénico/análisis , Medicamentos Herbarios Chinos/química , Estudios de Evaluación como Asunto , Xantenos/análisis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA